Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5600
0.048.23%
At close: -
$0.5350
-0.03-4.46%
After Hours: May 16, 7:54 PM EDT
Comments
Loading...
Century Therapeutics Stock Price, Quotes and Forecasts
IPSCNASDAQ
Century Therapeutics (IPSC) Forecast
NewsEarningsCentury Therapeutics (IPSC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Century Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:IPSC | Benzinga
Explore Century Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IPSC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Century Therapeutics (IPSC) stock?
You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.
Who are Century Therapeutics (IPSC) competitors?
Other companies in Century Therapeutics’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Century Therapeutics (IPSC) stock?
Century Therapeutics has a consensus price target of $9.86.
What is the current price for Century Therapeutics (IPSC)?
The stock price for Century Therapeutics (NASDAQ: IPSC) is $0.535 last updated May 16, 2025 at 7:54 PM EDT.
Does Century Therapeutics (IPSC) pay a dividend?
There are no upcoming dividends for Century Therapeutics.
When is Century Therapeutics (NASDAQ:IPSC) reporting earnings?
Century Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Century Therapeutics (IPSC) going to split?
There is no upcoming split for Century Therapeutics.
What sector and industry does Century Therapeutics (IPSC) operate in?
Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
